Skip Navigation


Annals of Oncology Advance Access originally published online on May 4, 2005
Annals of Oncology 2005 16(9):1557; doi:10.1093/annonc/mdi263
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/9/1557-a    most recent
mdi263v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Repetto, L.
Right arrow Articles by Gazzaniga, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Repetto, L.
Right arrow Articles by Gazzaniga, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Impact of EGFR expression on colorectal cancer patient prognosis and survival: a response

The first 10% of the full text of this article appears below.

We recently read the article from Spano et al. [1Go], which describes the impact of epidermal growth factor receptor (EGFR) detection on colorectal cancer patient survival. Although we found . . . [Full Text of this Article]

L. Repetto1, W. Gianni1, A. M. Aglianò2 and P. Gazzaniga2,*

1 INRCA, Unità Operativa Oncologica, Sede di Roma, Rome; 2 Dipartimento di Medicina Sperimentale e Patologia, Università degli Studi di Roma, Rome, Italy

(* Email: paola.gazzaniga@uniroma1.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?